Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
bi-4SCAR CD19/22 T / SZGIMI
NCT05432882: CD19/22 Bi-specific CAR-T Cell Therapy	Recruiting	1/2	60	RoW	bi-4SCAR CD19/22 T cells	Shenzhen Geno-Immune Medical Institute	B Cell Malignancies	12/25	06/26